Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Jul 20:35:10465.
doi: 10.3389/ti.2022.10465. eCollection 2022.

The Role of Fc Gamma Receptors in Antibody-Mediated Rejection of Kidney Transplants

Affiliations
Review

The Role of Fc Gamma Receptors in Antibody-Mediated Rejection of Kidney Transplants

Boris Delpire et al. Transpl Int. .

Abstract

For the past decades, complement activation and complement-mediated destruction of allograft cells were considered to play a central role in anti-HLA antibody-mediated rejection (AMR) of kidney transplants. However, also complement-independent mechanisms are relevant in the downstream immune activation induced by donor-specific antibodies, such as Fc-gamma receptor (FcγR)-mediated direct cellular activation. This article reviews the literature regarding FcγR involvement in AMR, and the potential contribution of FcγR gene polymorphisms to the risk for antibody mediated rejection of kidney transplants. There is large heterogeneity between the studies, both in the definition of the clinical phenotypes and in the technical aspects. The study populations were generally quite small, except for two larger study cohorts, which obviates drawing firm conclusions regarding the associations between AMR and specific FcγR polymorphisms. Although FcγR are central in the pathophysiology of AMR, it remains difficult to identify genetic risk factors for AMR in the recipient's genome, independent of clinical risk factors, independent of the donor-recipient genetic mismatch, and in the presence of powerful immunosuppressive agents. There is a need for larger, multi-center studies with standardised methods and endpoints to identify potentially relevant FcγR gene polymorphisms that represent an increased risk for AMR after kidney transplantation.

Keywords: AMR; FcγR; FcγR polymorphism; antibody-mediated rejection; kidney transplant; renal transplantation.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

FIGURE 1
FIGURE 1
Cellular distribution and function of FcγRs [Adapted from Castro-Dopico et al. (41)]. Multiple immune cells are implicated in AMR and express FcγRs. By promoting cell-type-specific immunological mechanisms they contribute to allograft rejection. B-cells only contain the inhibitory FcγRIIB, which is why they lead to BCR inhibition and apoptosis. NK-cells only express activating FcγRs which is why they only lead to activation of immunological mechanisms such as ADCC and cytokine production. Dendritic cells, macrophages and monocytes contain both activating and inhibitory FcγRs. ADCC, antibody-dependent cellular cytotoxicity; ROS, reactive oxygen species; NET, neutrophil extracellular traps; BCR, B-cell receptor.

References

    1. Abecassis M, Bartlett ST, Collins AJ, Davis CL, Delmonico FL, Friedewald JJ, et al. Kidney Transplantation as Primary Therapy for End-Stage Renal Disease: A National Kidney Foundation/Kidney Disease Outcomes Quality Initiative (NKF/KDOQI) Conference. Clin J Am Soc Nephrol (2008) 3(2):471–80. 10.2215/cjn.05021107 - DOI - PMC - PubMed
    1. Nankivell BJ, Kuypers DR. Diagnosis and Prevention of Chronic Kidney Allograft Loss. Lancet (2011) 378(9800):1428–37. 10.1016/S0140-6736(11)60699-5 - DOI - PubMed
    1. Sellarés J, de Freitas DG, Mengel M, Reeve J, Einecke G, Sis B, et al. Understanding the Causes of Kidney Transplant Failure: The Dominant Role of Antibody-Mediated Rejection and Nonadherence. Am J Transpl (2012) 12(2):388–99. 10.1111/j.1600-6143.2011.03840.x - DOI - PubMed
    1. van Loon E, Bernards J, van Craenenbroeck AH, Naesens M. The Causes of Kidney Allograft Failure: More Than Alloimmunity. A Viewpoint Article. Transplantation (2020) 104(2):E46–56. 10.1097/TP.0000000000003012 - DOI - PubMed
    1. Mayrdorfer M, Liefeldt L, Wu K, Rudolph B, Zhang Q, Friedersdorff F, et al. Exploring the Complexity of Death-Censored Kidney Allograft Failure. J Am Soc Nephrol (2021) 32(6):1513–26. 10.1681/asn.2020081215 - DOI - PMC - PubMed